相关实验视频
Updated: Jan 15, 2026
07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
34.8K
阿特拉提洛德巨头类化合物通过对NF-κB通路的多目标调节减轻儿科神经炎症
Aiyuan Cai1, Ran Liu1, Zilong Li1
1Department of Pediatrics, Longhua District People's Hospital, Shenzhen, 518109, Guangdong, China.
Scientific reports
|October 10, 2025
概括
通过向核因子kappa-B (NF-κB) 途径和改善线粒体功能,Atractylodes macrocephala和Atractylenolide III可以减少儿科中中枢神经系统的炎症.
科学领域:
- 草药研究 草药研究
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿科包括中枢神经系统 (CNS) 的炎症.
- 虫巨头 (AM) 和其组成部分Atractylenolide III (ATR-III) 显示出潜在的抗炎作用.
- 核因子kappa-B (NF-κB) 信号通路与神经炎症有关.
研究的目的:
- 研究小儿症中AM和ATR-III的多目标机制.
- 阐明它们在通过NF-κB通路调节中枢神经系统炎症反应中的作用.
- 评估它们在炎症背景下对线粒体功能的影响.
主要方法:
- 网络药理学以确定AM的活性成分和标.
- 整合儿童的目标,然后进行基因本体学 (GO) 和基因和基因组 (KEGG) 分析的京都百科全书.
- 通过使用LPS诱导的微质炎症模型,ATR-III与关键点和体外研究的分子对接.
主要成果:
- 网络药理学确定了AM和儿科之间的重叠目标,富含神经炎症路径.
- 分子对接证实了ATR-III与NF-κB点的强有力的结合.
- 在体外研究表明,ATR-III抑制NF-κB激活,减少炎症性细胞因子,并改善线粒体功能.
结论:
- AM和ATR-III表现出减少儿童中中枢神经系统炎症的多目标机制.
- ATR-III有效调节NF-κB通路并增强线粒体功能.
- 这些发现为使用AM治疗儿科提供了理论基础,并强调ATR-III作为潜在的天然抗炎剂.
相关概念视频
01:14Antiepileptic Drugs: Glutamate Antagonists
893
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
893
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
822
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
822
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
01:20Antiepileptic Drugs: Potassium Channel Activators
632
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
632